MEDLIVE (02192): Share Repurchase

MEDLIVE (02192) announced that the company commenced repurchasing its shares on the open market on October 26, 2026. The share repurchase is conducted pursuant to the general mandate for share buy-backs granted by the company's shareholders at the annual general meeting held on May 15, 2026, with the repurchase funds coming from the company's internal resources. The company believes that its current share price level does not yet fully reflect its long-term value. After evaluating the company's long-term development prospects and carefully considering shareholders' interests, the company will, within the scope of the buy-back mandate and subject to compliance with applicable laws, regulations and regulatory requirements, prudently and orderly implement the on-market share repurchase arrangements.